Member

In many ways, we have asked the question: is it possible to find a way to scrap CTOs for the majority of those for whom they are ineffective, while finding a way to continue their use for that small group of people who may still benefit? I hope that this review would answer that question and perhaps other relevant questions, but also allow us to follow a path that would deliver therapeutic benefit while at the same time align with the principle of least restriction.